Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 143

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 143
---
                                            |

| ● | the absence of any material misstatement or omission in the registration statement that includes this 
 prospectus;                                                                                           |

| ● | the final prospectus, in final form, and all reports, schedules, registrations, forms, statements, information                            
 and other documents required to have been filed by us with the SEC pursuant to the reporting requirements of the Exchange Act having been 
 so filed;                                                                                                                                 |

| ● | the Common Stock not having been suspended by the SEC, Nasdaq or FINRA and there not having been imposed             
 any suspension of, or restriction on, accepting additional deposits of Common Stock by The Depository Trust Company; |

76

| ● | no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in 
 the Keystone Purchase Agreements) shall have occurred and be continuing;                                |

| ● | customary compliance with laws and bankruptcy-related conditions; and |

| ● | the receipt by Keystone of customary legal opinions, as required under the Purchase Agreement. |

Termination of the Keystone Purchase Agreements Unless earlier terminated as provided in the Keystone Purchase Agreements, the Keystone Purchase Agreements will terminate automatically on the earliest to occur of:

| ● | the 36-month anniversary of the effective date of the applicable Registration Statement; |

| ● | the date on which Keystone has purchased the Keystone Commitment Amount pursuant to the Keystone Purchase 
 Agreements;                                                                                               |

| ● | the date on which our Common Stock fails to be listed or quoted on the Nasdaq or any Eligible Market; 
 and                                                                                                   |

| ● | the 30th trading day following the date on which, pursuant to or within the meaning of any bankruptcy                                          
 law, we commence a voluntary case or any person commences a proceeding against us, a custodian is appointed for us or for all or substantially 
 all of our property, or we make a general assignment for the benefit of our creditors.                                                         |

We have the right to terminate the Keystone Purchase Agreements at any time after the Keystone Commencement Date, at no cost or penalty, upon one trading days’ prior written notice to Keystone, provided that we shall have issued all Keystone Commitment Shares to Keystone prior to such termination. We and Keystone may also terminate the Keystone Purchase Agreements at any time by mutual written consent. Keystone also has the right to terminate the Keystone Purchase Agreements upon 10 trading days’ prior written notice to us, but only upon the occurrence of certain customary events as listed in the Keystone Purchase Ag